Our portfolio

InSteps

Providing in-silico modeling for stroke treatment, InSteps develops a platform to simulate various stroke scenarios. Their technology aids in the development of thrombectomy devices and optimizes clinical trials, giving more patients access to life-saving treatments. The company is committed to enhancing stroke care through advanced simulation technology.

Industry: Neuroscience, Simulation, Stroke

Want to get in contact about InSteps?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.
Enhancing plant growth with solar-powered nanotechnology.
Developing a painless and more accurate mammography technology for breast cancer detection.
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.
Enhancing plant growth with solar-powered nanotechnology.
Developing a painless and more accurate mammography technology for breast cancer detection.